Larvol Delta - BioPath-Holdings-Announces-Clearance-of-Investigational-New-Drug-Application-for-Phase-11b-Clinical-Trial-of-PrexigebersenA-in-Solid-Tumors

prexigebersen (BP1001) - Bio-Path

https://www.globenewswire.com/news-release/2021/10/27/2321564/0/en/Bio-Path-Holdings-Announces-Clearance-of-Investigational-New-Drug-Application-for-Phase-1-1b-Clinical-Trial-of-Prexigebersen-A-in-Solid-Tumors.html

Oct 27, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next